Does SERPLULIMAB Cause Myelosuppression? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Myelosuppression have been filed in association with SERPLULIMAB. This represents 9.5% of all adverse event reports for SERPLULIMAB.
13
Reports of Myelosuppression with SERPLULIMAB
9.5%
of all SERPLULIMAB reports
5
Deaths
3
Hospitalizations
How Dangerous Is Myelosuppression From SERPLULIMAB?
Of the 13 reports, 5 (38.5%) resulted in death, 3 (23.1%) required hospitalization, and 2 (15.4%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SERPLULIMAB. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does SERPLULIMAB Cause?
Neutrophil count decreased (19)
Platelet count decreased (18)
Pneumonia (17)
White blood cell count decreased (17)
Anaemia (15)
Neutropenia (11)
Nausea (10)
Thrombocytopenia (10)
Off label use (8)
Pneumonitis (8)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which SERPLULIMAB Alternatives Have Lower Myelosuppression Risk?
SERPLULIMAB vs SERTRALINE
SERPLULIMAB vs SEVELAMER
SERPLULIMAB vs SEVOFLURANE
SERPLULIMAB vs SILDENAFIL
SERPLULIMAB vs SILTUXIMAB